INTERPRETING TRIALS OF BONE-ACTIVE AGENTS

被引：24
|
作者：
HEANEY, RP
机构：
来源：
AMERICAN JOURNAL OF MEDICINE | 1995年 / 98卷 / 04期
关键词：
D O I：
10.1016/S0002-9343(99)80309-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [21] Synthesis and Characterization of a Biocomposite Bone Bandage for Controlled Delivery of Bone-Active Drugs in Fracture Nonunions
    Raina, Deepak Bushan
    Glencross, Alexandra
    Chaher, Nadia
    Liu, Yang
    Lidgren, Lars
    Isaksson, Hanna
    Tagil, Magnus
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2020, 6 (05): : 2867 - 2878
  • [22] Impact of bone-active drugs and underlying disease on bone health after lung transplantation: A longitudinal study
    Giorgia, Grassi
    Iacopo, Chiodini
    Elisa, Cairoli
    Morlacchi, Letizia Corinna
    Valeria, Rossetti
    Lorenzo, Rosso
    Ilaria, Righi
    Mario, Nosotti
    Maura, Arosio
    Francesco, Blasi
    Cristina, Eller-Vainicher
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (06) : E100 - E107
  • [23] Extracellular matrix changes in knee joint cartilage following bone-active drug treatment
    Horst Claassen
    Christian Cellarius
    Katharina E. Scholz-Ahrens
    Jürgen Schrezenmeir
    Claus-Christian Glüer
    Michael Schünke
    Bodo Kurz
    Cell and Tissue Research, 2006, 324
  • [24] THE DESIGN AND SYNTHESIS OF BONE-ACTIVE PHOSPHINIC ACID ANALOGS .1. THE PYRIDYLAMINOMETHANE PHOSPHONALKYLPHOSPHINATES
    EBETINO, FH
    JAMIESON, LA
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 1990, 51 (1-4): : 23 - 26
  • [25] Extracellular matrix changes in knee joint cartilage following bone-active drug treatment
    Claassen, H
    Cellarius, C
    Scholz-Ahrens, KE
    Schrezenmeir, J
    Glüer, CC
    Schünke, M
    Kurz, B
    CELL AND TISSUE RESEARCH, 2006, 324 (02) : 279 - 289
  • [26] Effects of bone active agents on bone quality
    Burr, DB
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S73 - S74
  • [27] Intrapulmonary drug delivery of bone-active peptides: Bioactivity of inhaled calcitonin approximates injected calcitonin.
    Deftos, LJ
    Nolan, JJ
    Seely, BL
    Clopton, PC
    Cote, GJ
    Whitham, CL
    Florek, LJ
    Christensen, TA
    Hill, MR
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : 4 - 4
  • [28] Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies
    Birtolo, Maria Francesca
    Pedersini, Rebecca
    Palermo, Andrea
    Vena, Walter
    Morenghi, Emanuela
    Cristofolini, Giacomo
    Presciuttini, Barbara
    Tabacco, Gaia
    Naciu, Anda Mihaela
    Pigni, Stella
    Lagana, Marta
    Mazzoleni, Federica
    Cosentini, Deborah
    Ciafardini, Antea
    Pagani, Mauro
    Farina, Davide
    Balzarini, Luca
    Zambelli, Alberto
    Torrisi, Rosalba
    Cianferotti, Luisella
    Napoli, Nicola
    Bossi, Antonio Carlo
    Lania, Andrea Gerardo
    Berruti, Alfredo
    Mazziotti, Gherardo
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2024, 191 (02) : 116 - 124
  • [29] Interpreting randomised trials evaluating newer agents or interferon in multiple sclerosis
    Messori, Andrea
    Del Santo, Fabiola
    Maratea, Dario
    Fadda, Valeria
    Trippoli, Sabrina
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (08) : 1225 - 1226
  • [30] CHROMOGRANIN-A (CHR-A) IS CO-SECRETED WITH BONE-ACTIVE PEPTIDES AND OTHER HORMONES IN HUMANS
    DEFTOS, LJ
    OCONNOR, DT
    JOURNAL OF BONE AND MINERAL RESEARCH, 1986, 1 (01) : 155 - 155
12345